IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
Top Cited Papers
Open Access
- 23 February 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (8), 1901-1903
- https://doi.org/10.1182/blood-2011-11-391748
Abstract
Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) occur in most grade 2 and 3 gliomas, secondary glioblastomas, anKeywords
This publication has 19 references indexed in Scilit:
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsThe Journal of Experimental Medicine, 2010
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaBlood, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsBlood, 2008
- Pathobiology and Molecular Profiling of Peripheral T-Cell LymphomasHematology-American Society Hematology Education Program, 2008
- High-throughput oncogene mutation profiling in human cancerNature Genetics, 2007
- Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cellsBlood, 2006